Xspray aims for up-listing first half of 2020
STOCKHOLM – September 10, 2019. Xspray Pharma (Nasdaq First North Growth Market: XSPRAY) revises the schedule for its planned list change from Nasdaq First North Growth Market to Nasdaq Stockholm, with the goal to complete the up-listing in the first half of 2020.On October 25, 2018, Xspray announced the Board of directors’ decision to apply for listing of the company’s share on Nasdaq Stockholm’s main list, and that the up-listing was expected to take place within 12 months. Due to the resource-demanding work that is currently in progress, primarily production, clinical and business